Thyroid Autoantibodies and Fatty Liver Disease in Diabetes
Author Information
Author(s): Wu Wenchang, Yang Ziyi, Li Owen, Gan Lulu, Gao Yue, Xiang Cheng, Li Ling, Yan Yimin
Primary Institution: Wuhan University of Science and Technology
Hypothesis
This study aims to explore the relationship between thyroid peroxidase antibody (TPOAb) and thyroglobulin antibody (TgAb) levels and metabolic dysfunction-associated fatty liver disease (MAFLD) in patients with type 2 diabetes mellitus (T2DM).
Conclusion
Elevated TSH and TPOAb levels are risk factors for MAFLD in T2DM patients.
Supporting Evidence
- 73.46% of MAFLD patients were overweight or obese.
- MAFLD prevalence was positively correlated with TgAb and TPOAb levels.
- Elevated TSH and TPOAb levels were identified as significant risk factors for MAFLD.
Takeaway
This study found that people with diabetes and fatty liver disease often have higher levels of certain thyroid antibodies, which might make their liver problems worse.
Methodology
The study included 534 T2DM patients, with 432 meeting the criteria after exclusions, and analyzed their thyroid function and antibody levels in relation to MAFLD.
Potential Biases
Potential confounding from unmeasured factors cannot be ruled out.
Limitations
The cross-sectional design limits causal inference, and there may be selection bias affecting generalizability.
Participant Demographics
The average age of participants was 54.65 years, with 60.3% male and 39.7% female.
Statistical Information
P-Value
P<0.001 for TSH and TPOAb as risk factors.
Confidence Interval
95% CI: 1.213-1.712 for TPOAb
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website